Author

Juan Fu

Primary ORCID profile (0000-0002-7957-1409 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Juan FuiD1 paper · Norwegian University of Life Sciences

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Amit Kumar· 1 shared C. Korin BulleniD· 1 shared Drew M. Pardoll· 1 shared Elizabeth A. Ihms· 1 shared Garrett Patrick· 1 shared John R. Murphy· 1 shared Laurene S. Cheung· 1 shared Michael E. Urbanowski· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amit Kumar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A second generation IL-2 receptor-targeted diphtheria fusion toxin exhibits anti-tumor activity and synergy with anti-PD-1 in melanoma

Laurene S. Cheung, Juan Fu, Pankaj Kumar, Amit Kumar, Michael E. Urbanowski, Elizabeth A. Ihms, Sadiya Parveen, C. Korin Bullen, Garrett Patrick, Robert Harrison, John R. Murphy, Drew M. Pardoll, William R. Bishai

This paper describes a second-generation diphtheria toxin-based fusion protein with reduced vascular leak and improved therapeutic activity in melanoma when used alone or with anti-PD-1.

bioRxiv · Sep 17, 2018 · PreprintCancer Biology